High risk metastatic hormone sensitive prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Chromosomes, Human, Pair 8 Neoplastic Stem Cells Seminal Vesicles Cell Line Cell Nucleus Rectum Pituitary Gland Stromal Cells Neoplastic Cells, Circulating

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases31

Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Disease Progression Neoplasm Metastasis Adenocarcinoma Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Carcinoma Neoplasm Recurrence, Local Lung Neoplasms Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Urinary Bladder Neoplasms Uterine Cervical Neoplasms Neovascularization, Pathologic Colorectal Neoplasms Disease Models, Animal Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating

Chemicals and Drugs83

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Hormones Thyroid Hormones Tumor Markers, Biological Follicle Stimulating Hormone Gonadotropin-Releasing Hormone Luteinizing Hormone Tosyl Compounds Gonadal Steroid Hormones Antineoplastic Agents, Hormonal RNA, Messenger Antineoplastic Agents Parathyroid Hormone Neoplasm Proteins Androgen Receptor Antagonists Dihydrotestosterone Anilides Testosterone Finasteride Metribolone Flutamide Receptors, Thyroid Hormone Anticarcinogenic Agents RNA, Small Interfering Human Growth Hormone Cancer Vaccines Taxoids Adrenocorticotropic Hormone Estradiol Glutamate Carboxypeptidase II DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Pituitary Hormones Testosterone Congeners Transcription Factors Leuprolide Nitriles Antigens, Neoplasm Antineoplastic Agents, Phytogenic 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Estrogens Androstenols Receptors, Estrogen Proto-Oncogene Proteins c-akt Azasteroids Phenylthiohydantoin Triiodothyronine RNA, Neoplasm Tumor Suppressor Protein p53 Insulin-Like Growth Factor I DNA-Binding Proteins Goserelin Juvenile Hormones Racemases and Epimerases Growth Hormone-Releasing Hormone Receptor, erbB-2 Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase MicroRNAs Estramustine Prolactin DNA Primers Receptors, Progesterone Steroid 17-alpha-Hydroxylase Glutathione S-Transferase pi Antibodies, Monoclonal Enzyme Inhibitors Peptide Hormones Proto-Oncogene Proteins Insulin-Like Growth Factor Binding Protein 3 Androgen-Binding Protein Proto-Oncogene Proteins c-bcl-2 Nuclear Proteins Corticotropin-Releasing Hormone Kallikreins Thyroxine Tamoxifen Prostatic Secretory Proteins Paclitaxel

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Prostatectomy Orchiectomy Early Detection of Cancer Risk Factors Neoplasm Staging Neoplasm Grading Prognosis Reverse Transcriptase Polymerase Chain Reaction Risk Risk Assessment Prospective Studies Xenograft Model Antitumor Assays Follow-Up Studies Case-Control Studies Immunohistochemistry Digital Rectal Examination Neoplasm Transplantation Retrospective Studies Blotting, Western Transplantation, Heterologous Treatment Outcome Gene Expression Profiling Sensitivity and Specificity Survival Rate Survival Analysis Cohort Studies Incidence Transurethral Resection of Prostate Biopsy Odds Ratio Castration Transfection Predictive Value of Tests Biopsy, Needle Multivariate Analysis Disease-Free Survival Combined Modality Therapy Brachytherapy Oligonucleotide Array Sequence Analysis Tumor Burden Polymerase Chain Reaction Logistic Models Registries Antineoplastic Combined Chemotherapy Protocols Tissue Array Analysis SEER Program Hormone Replacement Therapy Questionnaires Mass Screening Kaplan-Meier Estimate Radiotherapy Reproducibility of Results Models, Biological Nomograms Radiotherapy Dosage Radiotherapy, Conformal Molecular Targeted Therapy Drug Screening Assays, Antitumor Confidence Intervals Clinical Trials as Topic Immunoenzyme Techniques Disease Models, Animal Gene Knockdown Techniques Flow Cytometry Proportional Hazards Models ROC Curve In Situ Hybridization, Fluorescence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Chemotherapy, Adjuvant Drug Administration Schedule

Psychiatry and Psychology1

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Cell Proliferation Genetic Predisposition to Disease Apoptosis Risk Signal Transduction Time Factors Sensitivity and Specificity Genotype Down-Regulation Cell Division Cell Growth Processes Drug Resistance, Neoplasm Odds Ratio Transfection Dose-Response Relationship, Drug Cell Survival Promoter Regions, Genetic Mutation Cell Movement Up-Regulation Base Sequence DNA Methylation Polymorphism, Genetic Cell Cycle Gene Expression Transcription, Genetic Nomograms Gene Silencing RNA Interference Diet Gene Fusion Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Phosphorylation Polymorphism, Single Nucleotide Alleles Phenotype Germ-Line Mutation Drug Synergism Genes, Neoplasm Amino Acid Sequence Protein Binding Genes, BRCA1 Transcriptional Activation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Molecular Sequence Data Base Sequence Registries SEER Program Questionnaires Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Amino Acid Sequence Radiotherapy Planning, Computer-Assisted

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care32

Risk Factors Risk Risk Assessment Prospective Studies Follow-Up Studies Case-Control Studies Watchful Waiting Retrospective Studies Treatment Outcome Sensitivity and Specificity Survival Rate Survival Analysis Cohort Studies Incidence Odds Ratio Age Factors Predictive Value of Tests Multivariate Analysis Disease-Free Survival Logistic Models Registries SEER Program National Cancer Institute (U.S.)Questionnaires Mass Screening Kaplan-Meier Estimate Reproducibility of Results Nomograms Confidence Intervals Clinical Trials as Topic Proportional Hazards Models ROC Curve

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Prostatic Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Hormones Prostatic Hyperplasia Orchiectomy Gene Expression Regulation, Neoplastic Neoplasms, Hormone-Dependent Early Detection of Cancer Thyroid Hormones Tumor Markers, Biological Disease Progression Follicle Stimulating Hormone Neoplasm Metastasis Risk Factors Adenocarcinoma Mice, Nude Prostatic Intraepithelial Neoplasia Gonadotropin-Releasing Hormone Luteinizing Hormone Tosyl Compounds Bone Neoplasms Neoplasm Invasiveness Gonadal Steroid Hormones Neoplasm Staging Neoplasm Grading Prognosis Cell Proliferation Antineoplastic Agents, Hormonal RNA, Messenger Tumor Cells, Cultured Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Agents Breast Neoplasms Apoptosis Parathyroid Hormone Neoplasm Proteins Androgen Receptor Antagonists Dihydrotestosterone Risk Risk Assessment Prospective Studies Xenograft Model Antitumor Assays Anilides Follow-Up Studies Case-Control Studies Immunohistochemistry Digital Rectal Examination Testosterone Signal Transduction Neoplasm Transplantation Watchful Waiting Retrospective Studies Neoplasms Blotting, Western Finasteride Transplantation, Heterologous Treatment Outcome Gene Expression Profiling Time Factors Carcinoma Neoplasm Recurrence, Local Sensitivity and Specificity Lung Neoplasms Survival Rate Survival Analysis Metribolone United States Cohort Studies Flutamide Incidence Ovarian Neoplasms Transurethral Resection of Prostate Biopsy Genotype Down-Regulation Receptors, Thyroid Hormone Cell Division Cell Growth Processes Drug Resistance, Neoplasm Anticarcinogenic Agents RNA, Small Interfering Odds Ratio Human Growth Hormone Prostatic Neoplasms, Castration-Resistant Age Factors Castration Transfection Predictive Value of Tests Dose-Response Relationship, Drug Cell Survival Cancer Vaccines Taxoids Adrenocorticotropic Hormone

No FAQ available that match "high risk metastatic hormone sensitive prostate cancer"